en.hdbuzz.net
Read the original →
SKY-0515 Lowers Huntingtin In People With Huntington's Disease In Trial Update
ASOs Restore Cognitive Deficits in Huntington Mice | Neurology Today
neurologytoday.aan.com · Oct 25, 2025 Standard
The Other Shoe Drops: uniQure Shares Plans To Submit Licensing Application With The FDA for AMT-130 – HDBuzz
en.hdbuzz.net · Jun 17, 2026 Standard
Skyhawk reports encouraging 12-month results for oral Huntington’s disease drug SKY-0515 – HDBuzz
en.hdbuzz.net · Jun 1, 2026 Standard
Two Years In: New Long-Term Extension Data from PIVOT-HD for Votoplam – HDBuzz
en.hdbuzz.net · May 4, 2026 Standard
Putting it in print: oral drug branaplam lowered huntingtin, but safety concerns halted development – HDBuzz
en.hdbuzz.net · Feb 12, 2026 Standard
A hitch in the stitch reveals why DNA sequence patterns matter in Huntington’s disease – HDBuzz
en.hdbuzz.net · Feb 9, 2026 Standard